﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>14</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>12</Month>
        <DAY>30</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Green Formulation of Menadione-Loaded Niosome as a Skin-Lightening Preparation: In Vitro/In Vivo Safety Evaluation on Wistar Rat</ArticleTitle>
    <FirstPage>858</FirstPage>
    <LastPage>869</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.42731</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Saeedi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-2617-9961</Identifier>
      </Author>
      <Author>
        <FirstName>Katayoun</FirstName>
        <LastName>Morteza-Semnani</LastName>
      </Author>
      <Author>
        <FirstName>Jafar</FirstName>
        <LastName>Akbari</LastName>
      </Author>
      <Author>
        <FirstName>Seyyed Mobin</FirstName>
        <LastName>Rahimnia</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1499-7668</Identifier>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Ahmadi</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Mojaveri</LastName>
      </Author>
      <Author>
        <FirstName>Saghar</FirstName>
        <LastName>Ahmadipour</LastName>
      </Author>
      <Author>
        <FirstName>Seyyed Mohammad Hassan</FirstName>
        <LastName>Hashemi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1148-180X</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.42731</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>09</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: In the present research, a green technique (an ultrasonic method) was used to synthesize menadione sodium bisulfite (MSB) niosome (Menasome) which is used to improve dermal delivery and increase anti-melanogenesis activities. Methods: Various cholesterol: surfactant (Chol: Sur) ratios were investigated to optimize the Menasomes. Photon correlation spectroscopy, attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), transmission electron microscopy (TEM), and differential scanning calorimetry (DSC) were employed to characterize the solid state of MSB in nanoparticle form. Additionally, the optimized formulation was used to investigate ex-vivo skin absorption, in vivo skin irritation, in vitro cell survival, and anti-melanogenesis activity. Results: The results exhibited that increasing cholesterol declined the average size of the Menasomes from 653.766±25.171 nm to 298.133±8.823 nm and increased entrapment efficiency 30.237±3.4204% to 83.616±2.550 %. The rat skin permeation study indicated that Menasome gel administered more MSB in dermal layers (439.000±36.190 μg/cm2 or 23.827±1.964%) than MSB plain gel (286.200±22.6 μg/cm2 or 15.53±1.227%). In both the in vivo skin irritation test and the in vitro cytotoxicity experiment, the extended-release behavior of the enhanced Menasome demonstrated a minimal side effect profile. Furthermore, optimum Menasome inhibited melanin formation (37.426±1.644% at 15μM) greater than free MSB (57.383±1.654%) considerably (P&lt;0.05). Furthermore, Menasome 7 prevented L-dopa auto-oxidation in higher levels (95.140±2.439%) than pure MSB solution (83.953±1.629%). Conclusion: According to the study’s findings, the prepared Menasome could be employed as a viable nanovehicle for MSB dermal delivery, a promising solution for the management of human hyperpigmentation disorders.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Green technique</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Anti-melanogenesis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Menadione</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Niosome</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cosmetic</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>